Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Cholangiocarcinoma × Exercise × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Motor Activity 12 Breast Neoplasms 9 Neoplasms 6 Leukemia, Myeloid, Acute 3 Prostatic Neoplasms 2 Patient Compliance 2 Neoplasm Metastasis 2 Fatigue 2 Depression 2 Colorectal Neoplasms 2 Brain Neoplasms 2 Weight Loss 1 Weight Gain 1 Smoking Cessation 1 Peripheral Nervous System Diseases 1 Overweight 1 Ovarian Neoplasms 1 Obesity 1 Neuroectodermal Tumors, Primitive 1 Medulloblastoma 1 Lung Neoplasms 1 Insulin Resistance 1 Infratentorial Neoplasms 1 Fallopian Tube Neoplasms 1 Disease 1 Cognitive Dysfunction 1 Cholangiocarcinoma 1 Carcinoma, Hepatocellular 1 Bone Metabolism Biomarkers 1 Body Weight Changes 1

Interventions

Gemcitabine 57 Cisplatin 31 Oxaliplatin 28 Fluorouracil 21 lenvatinib 19 durvalumab 18 Capecitabine 17 Leucovorin 15 pembrolizumab 10 tislelizumab 9 apatinib 9 Floxuridine 8 Specimen Handling 7 Panitumumab 7 Magnetic Resonance Spectroscopy 7 Albumin-Bound Paclitaxel 7 sintilimab 6 pemigatinib 6 Radiotherapy 6 Irinotecan 6 Drug Therapy 6 Biopsy 6 tremelimumab 5 olaparib 5 camrelizumab 5 Taxes 5 Nivolumab 5 Folfox protocol 5 Bevacizumab 5 130-nm albumin-bound paclitaxel 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02162914 2020-07-31

REACHIN

Erasme University Hospital

Phase 2 Unknown

Gastrointestinal

Neoplasm Metastasis, Cholangiocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡